Ann E. Kingston

3.2k total citations
51 papers, 2.7k citations indexed

About

Ann E. Kingston is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Ann E. Kingston has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Ann E. Kingston's work include Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Ann E. Kingston is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Ann E. Kingston collaborates with scholars based in United States, United Kingdom and Italy. Ann E. Kingston's co-authors include David Lodge, Darryle D. Schoepp, Rebecca A. Wright, James A. Monn, Stephen M. Fitzjohn, M J Colston, Bryan G. Johnson, Kristján R. Jessen, Graham L. Collingridge and Kristín Bergsteinsdóttir and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Comparative Neurology.

In The Last Decade

Ann E. Kingston

50 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ann E. Kingston 1.9k 1.3k 372 365 316 51 2.7k
Mark J. Wall 1.2k 0.6× 1.5k 1.1× 265 0.7× 409 1.1× 308 1.0× 97 3.0k
Verena Tretter 2.6k 1.4× 2.5k 1.9× 240 0.6× 497 1.4× 432 1.4× 50 4.1k
Marie‐Christine Miquel 1.4k 0.8× 1.6k 1.2× 394 1.1× 285 0.8× 175 0.6× 44 2.8k
Peter R. Maycox 1.8k 1.0× 2.3k 1.8× 348 0.9× 346 0.9× 139 0.4× 44 3.8k
John W. Ferkany 1.8k 0.9× 1.3k 1.0× 351 0.9× 306 0.8× 132 0.4× 59 2.5k
Cristina Cosi 1.1k 0.6× 939 0.7× 223 0.6× 150 0.4× 113 0.4× 51 2.1k
Chris Rundfeldt 2.3k 1.2× 1.6k 1.2× 390 1.0× 257 0.7× 60 0.2× 87 3.6k
Ingo H. Greger 2.4k 1.2× 2.5k 1.9× 177 0.5× 242 0.7× 231 0.7× 63 3.6k
George McAllister 1.4k 0.7× 2.2k 1.7× 253 0.7× 138 0.4× 79 0.3× 65 3.2k
Ana Luı́sa Carvalho 1.8k 0.9× 1.5k 1.2× 449 1.2× 333 0.9× 353 1.1× 78 3.2k

Countries citing papers authored by Ann E. Kingston

Since Specialization
Citations

This map shows the geographic impact of Ann E. Kingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Kingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Kingston more than expected).

Fields of papers citing papers by Ann E. Kingston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Kingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Kingston. The network helps show where Ann E. Kingston may publish in the future.

Co-authorship network of co-authors of Ann E. Kingston

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Kingston. A scholar is included among the top collaborators of Ann E. Kingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Kingston. Ann E. Kingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wright, Rebecca A., Bryan G. Johnson, Ce Zhang, et al.. (2012). CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography. Neuropharmacology. 66. 89–98. 72 indexed citations
3.
Lakics, Viktor, Hyoung‐gon Lee, Lisa M. Broad, et al.. (2009). Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide. Brain Research. 1260. 65–75. 75 indexed citations
4.
Szekeres, Philip, et al.. (2008). Development of Homogeneous 384-Well High-Throughput Screening Assays for Aβ1-40 and Aβ1-42 Using AlphaScreen™ Technology. SLAS DISCOVERY. 13(2). 101–111. 31 indexed citations
5.
Shannon, Harlan E., Steven Peters, & Ann E. Kingston. (2005). Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist. Neuropharmacology. 49. 188–195. 30 indexed citations
6.
Jong, Yuh‐Jiin I., Vikas Kumar, Ann E. Kingston, Carmelo Romano, & Karen L. O’Malley. (2005). Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons. Journal of Biological Chemistry. 280(34). 30469–30480. 94 indexed citations
7.
Gillard, Samantha, John A. Tzaferis, Ho‐Ching Tiffany Tsui, & Ann E. Kingston. (2003). Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus. The Journal of Comparative Neurology. 461(3). 317–332. 34 indexed citations
8.
Kingston, Ann E., Michael P. Johnson, Rosemarie Tomlinson, et al.. (2002). Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists. Neuroscience Letters. 330(2). 127–130. 31 indexed citations
9.
Thomas, Nicola, Rebecca A. Wright, Patrick A. Howson, et al.. (2001). (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology. 40(3). 311–318. 118 indexed citations
10.
Jones, Nicole M., C A Hicks, Mark Ward, et al.. (2000). Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo. Journal of Pharmacology and Experimental Therapeutics. 294(3). 800–809. 87 indexed citations
11.
Salt, T.E., J.P. Turner, & Ann E. Kingston. (1999). Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo. Neuropharmacology. 38(10). 1505–1510. 25 indexed citations
12.
Fitzjohn, Stephen M., Ann E. Kingston, David Lodge, & Graham L. Collingridge. (1999). DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists. Neuropharmacology. 38(10). 1577–1583. 145 indexed citations
13.
14.
Valli, Matthew J., Darryle D. Schoepp, Rebecca A. Wright, et al.. (1998). Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acid. Bioorganic & Medicinal Chemistry Letters. 8(15). 1985–1990. 11 indexed citations
15.
Fitzjohn, Stephen M., Zuner A. Bortolotto, Mary J. Palmer, et al.. (1998). The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology. 37(12). 1445–1458. 138 indexed citations
16.
Kingston, Ann E., J. Paul Burnett, Nancy G. Mayne, & David Lodge. (1995). Pharmacological analysis of 4-carboxyphenylglycine derivatives: Comparison of effects on mGluR1α and mGluR5a subtypes. Neuropharmacology. 34(8). 887–894. 83 indexed citations
17.
Kingston, Ann E., et al.. (1994). Cross-Reactivity to Proteoglycans in Bacterial Arthritis: Lack of Evidence for in Vivo Role in Induction of Disease. Clinical Immunology and Immunopathology. 71(3). 273–280. 5 indexed citations
18.
Kingston, Ann E., Stephen Carney, C A Hicks, & M. E. J. Billingham. (1993). In Vitro and in Vivo Effects of Proteoglycan Fractions in Adjuvant Treated Rats. Birkhäuser Basel eBooks. 39. 75–79. 1 indexed citations
19.
Bergsteinsdóttir, Kristín, Ann E. Kingston, Rhona Mirsky, & Kristján R. Jessen. (1991). Rat Schwann cells produce interleukin-1. Journal of Neuroimmunology. 34(1). 15–23. 78 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark J. Wall Breakdown of academic impact, for papers by Verena Tretter Breakdown of academic impact, for papers by Marie‐Christine Miquel Breakdown of academic impact, for papers by Peter R. Maycox Breakdown of academic impact, for papers by John W. Ferkany Breakdown of academic impact, for papers by Cristina Cosi Breakdown of academic impact, for papers by Chris Rundfeldt Breakdown of academic impact, for papers by Ingo H. Greger Breakdown of academic impact, for papers by George McAllister Breakdown of academic impact, for papers by Ana Luı́sa Carvalho
Rankless by CCL
2026